Skip to content

PSquared Asset Management AG

Follow

13F filer, CIK 1623624, ZURICH, Switzerland

PSquared Asset Management AG reported $305,993,735 across 18 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-17. Its ten largest share positions make up 92.2% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000945621-26-001069

Period
2026-06-30
Reported value
$306M
Holdings
18
Top 10 weight
92.2%
New
11
Sold out
8

Largest buys vs the previous quarter

SecurityShares changeApprox. value
EAnew+150,684$30.9M
LINnew+58,580$30.4M
KMBnew+150,147$16.5M
WBDadded+611,833$16.3M
TXNMnew+274,400$15.3M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
HOLXexited-405,920-$30.7M
GTLSexited-117,407-$24.3M
AAUCexited-740,000-$22.9M
FOLDexited-1,101,228-$15.9M
PENexited-42,785-$14M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0000945621-26-001069, largest first. % of portfolio is the value over $305,382,985, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
WBDWARNER BROS DISCOVERY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,540,876 shares; 2026Q1: 1,663,164 shares; 2026Q2: 2,274,997 shares 2,274,997$60.7M19.86%+611,833Timeline
IHSIHS HOLDING LIMITEDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 4,343,787 shares; 2026Q2: 4,321,436 shares 4,321,436$35.6M11.66%-22,351Timeline
SLSRSOLARIS RES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 4,547,184 shares; 2025Q2: 3,932,884 shares; 2025Q3: 3,924,058 shares; 2025Q4: 3,963,015 shares; 2026Q1: 4,084,315 shares; 2026Q2: 4,080,050 shares 4,080,050$34.3M11.24%-4,265Timeline
EAELECTRONIC ARTS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 150,684 shares 150,684$30.9M10.12%newTimeline
LINLINDE PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 58,580 shares 58,580$30.4M9.95%newTimeline
NSCNORFOLK SOUTHN CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 92,063 shares; 2026Q1: 96,385 shares; 2026Q2: 95,704 shares 95,704$30.1M9.86%-681Timeline
KMBKIMBERLY-CLARK CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 150,147 shares 150,147$16.5M5.4%newTimeline
TXNMTXNM ENERGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 274,400 shares 274,400$15.3M5.03%newTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 138,290 shares; 2026Q2: 80,000 shares 80,000$15M4.91%-58,290Timeline
EGOELDORADO GOLD CORP NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 409,853 shares 409,853$12.8M4.18%newTimeline
ESPRESPERION THERAPEUTICS INC NEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,300,000 shares 3,300,000$10.4M3.41%newTimeline
UNFUNIFIRST CORP MASSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 22,365 shares 22,365$5.91M1.94%newTimeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 240 shares; 2026Q1: 16,200 shares; 2026Q2: 41,200 shares 41,200$5.49M1.8%+25,000Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 35,000 shares; 2026Q2: 37,200 shares 37,200$2M0.65%+2,200Timeline
QXOQXO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 48 shares 48$829<0.01%newTimeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
RVMDREVOLUTION MEDICINES INC Stockcall600$444Knew
WBDWARNER BROS DISCOVERY INC Stockput10,000$130Knew
RVMDREVOLUTION MEDICINES INC Stockput700$36.8Knew

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
HOLXHOLOGIC INC405,920$30.7Mshares
GTLSCHART INDS INC117,407$24.3Mshares
AAUCALLIED GOLD CORP740,000$22.9Mshares
FOLDAMICUS THERAPEUTIC1,101,228$15.9Mshares
PENPENUMBRA INC42,785$14Mshares
PRAPROASSURANCE CORP368,059$9.1Mshares
ACLXARCELLX INC55,251$6.34Mshares
OLPXOLAPLEX HLDGS INC1,415,716$2.87Mshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000945621-26-001069 base2026-08-17acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0000945621-26-001069 Quarter ended 2026-06-302026-08-17acceptance time not in the bulk data set
13F-HR 0000945621-26-000698 Quarter ended 2026-03-312026-05-14acceptance time not in the bulk data set
13F-HR 0000945621-26-000319 Quarter ended 2025-12-312026-02-13acceptance time not in the bulk data set
13F-HR 0000945621-25-001083 Quarter ended 2025-09-302025-11-13acceptance time not in the bulk data set
13F-HR 0000943663-25-000218 Quarter ended 2025-06-302025-08-13acceptance time not in the bulk data set
13F-HR 0000943663-25-000122 Quarter ended 2025-03-312025-05-14acceptance time not in the bulk data set
13F-HR 0000943663-25-000045 Quarter ended 2024-12-312025-02-13acceptance time not in the bulk data set
13F-HR 0000943663-24-000264 Quarter ended 2024-09-302024-11-13acceptance time not in the bulk data set
13F-HR 0000943663-24-000199 Quarter ended 2024-06-302024-08-13acceptance time not in the bulk data set
13F-HR 0000943663-24-000122 Quarter ended 2024-03-312024-05-14acceptance time not in the bulk data set
13F-HR 0000943663-24-000046 Quarter ended 2023-12-312024-02-13acceptance time not in the bulk data set
13F-HR 0000943663-23-000184 Quarter ended 2023-09-302023-11-13acceptance time not in the bulk data set
13F-HR 0000894579-23-000234 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0001567619-23-006041 Quarter ended 2023-03-312023-05-11acceptance time not in the bulk data set
13F-HR 0001567619-23-002457 Quarter ended 2022-12-312023-02-13acceptance time not in the bulk data set
13F-HR 0001567619-22-019270 Quarter ended 2022-09-302022-11-08acceptance time not in the bulk data set
13F-HR 0001567619-22-015756 Quarter ended 2022-06-302022-08-12acceptance time not in the bulk data set
13F-HR 0001567619-22-010472 Quarter ended 2022-03-312022-05-13acceptance time not in the bulk data set
13F-HR 0001567619-22-003434 Quarter ended 2021-12-312022-02-11acceptance time not in the bulk data set
13F-HR 0001567619-21-020152 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-HR 0001567619-21-015411 Quarter ended 2021-06-302021-08-13acceptance time not in the bulk data set
13F-HR 0001567619-21-010040 Quarter ended 2021-03-312021-05-14acceptance time not in the bulk data set
13F-HR 0001567619-21-003337 Quarter ended 2020-12-312021-02-12acceptance time not in the bulk data set
13F-HR 0001567619-20-019361 Quarter ended 2020-09-302020-11-13acceptance time not in the bulk data set
13F-HR 0001567619-20-015005 Quarter ended 2020-06-302020-08-13acceptance time not in the bulk data set
13F-HR 0001567619-20-009930 Quarter ended 2020-03-312020-05-14acceptance time not in the bulk data set
13F-HR 0001567619-20-003167 Quarter ended 2019-12-312020-02-13acceptance time not in the bulk data set
13F-HR 0001567619-19-021110 Quarter ended 2019-09-302019-11-13acceptance time not in the bulk data set
13F-HR 0001567619-19-016447 Quarter ended 2019-06-302019-08-13acceptance time not in the bulk data set
13F-HR 0001567619-19-010667 Quarter ended 2019-03-312019-05-14acceptance time not in the bulk data set
13F-HR 0001567619-19-003422 Quarter ended 2018-12-312019-02-13acceptance time not in the bulk data set
13F-HR 0001567619-18-005672 Quarter ended 2018-09-302018-11-13acceptance time not in the bulk data set
13F-HR 0001567619-18-000465 Quarter ended 2018-06-302018-08-13acceptance time not in the bulk data set
13F-HR 0001140361-18-022933 Quarter ended 2018-03-312018-05-11acceptance time not in the bulk data set
13F-HR 0001140361-18-006795 Quarter ended 2017-12-312018-02-13acceptance time not in the bulk data set
13F-HR 0001140361-17-039054 Quarter ended 2017-09-302017-10-19acceptance time not in the bulk data set
13F-HR 0001140361-17-029514 Quarter ended 2017-06-302017-08-01acceptance time not in the bulk data set
13F-HR 0001140361-17-018020 Quarter ended 2017-03-312017-05-03acceptance time not in the bulk data set
13F-HR 0001140361-17-002996 Quarter ended 2016-12-312017-01-26acceptance time not in the bulk data set
13F-HR 0001140361-16-082878 Quarter ended 2016-09-302016-10-17acceptance time not in the bulk data set
13F-HR 0001140361-16-074943 Quarter ended 2016-06-302016-08-05acceptance time not in the bulk data set
13F-HR 0001140361-16-061412 Quarter ended 2016-03-312016-04-18acceptance time not in the bulk data set
13F-HR 0001140361-16-051665 Quarter ended 2015-12-312016-02-11acceptance time not in the bulk data set
13F-HR 0001140361-15-038297 Quarter ended 2015-09-302015-10-22acceptance time not in the bulk data set
13F-HR 0001140361-15-036256 Quarter ended 2015-03-312015-09-30acceptance time not in the bulk data set
13F-HR/A 0001140361-15-035756 Quarter ended 2014-12-312015-09-23acceptance time not in the bulk data set
13F-HR 0001140361-15-035725 Quarter ended 2015-06-302015-09-23acceptance time not in the bulk data set
13F-HR 0001140361-15-035641 Quarter ended 2014-12-312015-09-22acceptance time not in the bulk data set